Target intelligence / Profile preview

Transmembrane protein 241 pseudogene (No established canonical abbreviation (TMEM241 applies to the functional gene, not the pseudogene))

Target
No established canonical abbreviation (TMEM241 applies to the functional gene, not the pseudogene)
Molecular classification
Other (Pseudogene)
01

Overview

Transmembrane protein 241 pseudogene (ENSG00000270507) is a genomic locus that shares sequence similarity with the protein-coding transmembrane protein 241 gene (TMEM241/C18orf45), but is predicted to be nonfunctional due to accumulated mutations such as frameshifts or premature stop codons[1][5]. Pseudogenes are recognized by their high homology to active genes and their loss of protein-coding capability, usually resulting from evolutionary disablement[1][3][5]. While rare functional roles have been described for select pseudogenes (regulation of gene expression, possible siRNA involvement[7]), the majority—including this one—do not contribute to drug action or direct disease mechanisms and should not be considered molecular targets for therapy or diagnostics. Their classification is "pseudogene," which distinguishes them from recognized molecular target families such as receptor, transporter, or enzyme[1][5]. Pseudogenes, including this one, can complicate molecular genetics studies due to sequence similarity with functional genes, sometimes leading to amplification bias in PCR-based research[5]. There is no evidence that the transmembrane protein 241 pseudogene produces a functional protein or is involved in established drug, biomarker, or disease processes.

Other names
C18orf45FLJ44259MGC11386hVVT
02

Mechanism of action

None applicable. No mechanisms of action exist for therapeutics targeting this pseudogene.

03

Biological functions

Other (No known direct biological function; pseudogenes are most often nonfunctional but can occasionally impact gene regulation[1][5][7])
04

Disease associations

Other (No well-established roles in disease; most pseudogenes are not involved directly in disease, though some rare pseudogenes may have regulatory activities[1][5][7])

Beyond the preview

Go deeper on Transmembrane protein 241 pseudogene (No established canonical abbreviation (TMEM241 applies to the functional gene, not the pseudogene)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 241 pseudogene (No established canonical abbreviation (TMEM241 applies to the functional gene, not the pseudogene)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call